Cutis Marmorta Telangiectatica Congentia (CMTC)
Also known as: CMTC
What is Cutis Marmorta Telangiectatica Congentia (CMTC)?
Cutis marmorata telangiectatica congenita (CMTC) is an uncommonly reported, sporadic, congenital cutaneous disorder with persistent cutis marmorata, telangiectasia, and phlebectasia. Ulceration of the involved skin and cutaneous atrophy is described in a number of cases.
In addition, CMTC is often reported in association with a variety of other congenital anomalies, including but not limited to undergrowth or overgrowth of an involved extremity. Congenital disorder which is present at birth or shortly after.
CMTC principally affects the skin. CMTC tends to occur more frequently on the lower limbs, although the upper extremities, trunk, and face may also be involved. When located on the trunk, CMTC tends to have a midline distribution.
The primary lesion is characterized by pinkish blue, reticular, and patchy skin changes. Lesions may be localized or generalized.
Conditions frequently associated with CMTC:
- Skin atrophy and ulcerations
- capillary malformations (i.e., nevus flammeus)
- capillary and cavernous hemangioma
- atrophy or hypertrophy of the affected extremity
- macrocephaly (macrocephaly cutis marmorata telangiectatica congenita syndrome)
Other conditions associated with CMTC may include the following:
- Body asymmetry (hypoplasia and hypertrophy of the affected limbs)
- Vascular anomalies (capillary and cavernous hemangiomas, nevus flammeus, Sturge-Weber syndrome, Klippel-Trenaunay syndrome, Adams Oliver syndrome
- Glaucoma and retinal detachment
- Cutaneous atrophy
- Neurologic anomalies
Treatment for Cutis Marmorata Telangiectatica Congenita (CMTC)
The port wine stain (PWS)
component of CMTC as well as any residual net-like vascular patches can be treated with pulsed dye laser.
This page was last updated on: 1/10/2017 10:00:32 AM
From the Newsdesk
Just a few weeks after Brianna was born, her mother noticed a red growth on her daughter’s upper lip. Her pediatrician referred the family to specialists who diagnosed the growth as an Infantile Hemangioma. On December 7th, Dr. Chad Perlyn of Nickalus Children's Hospital, removed the hemangioma.
The Vascular Birthmarks Foundation presented Dr. Ana Duarte with a 2016 Physician of the Year Award for outstanding service in the diagnosis and treatment of children affected by a vascular birthmark.